Overcoming Immunogenicity in AAV Gene Therapies
Time: 10:00 am
day: Conference Day One - AM
Details:
- The importance of AAV antibody testing in overcoming immunogenicity challenges, ensuring treatment safety, and efficacy
- Best practices for assay and companion diagnostic development, emphasizing early development, assay format selection, and regulatory expertise
- Quest Diagnostics' pioneering approach to AAV antibody testing: from assay development and validation to supporting strategic immunomodulation
